Pharmaceuticals in Singapore

Date: June 30, 2017
Pages: 38
Price:
US$ 350.00 US$ 315.00
Offer valid until September 1, 2017!
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P5B6478CDADEN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in Singapore
Pharmaceuticals in Singapore

SUMMARY

Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

SYNOPSIS

Essential resource for top-line data and analysis covering the Singapore pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

KEY HIGHLIGHTS
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2016 annual average exchange rates.
  • The Singaporean pharmaceuticals market had total revenues of $0.9bn in 2016, representing a compound annual growth rate (CAGR) of 8.4% between 2012 and 2016.
  • Total healthcare expenditure is expected to continue to grow very rapidly and has already increased almost 300% over the past decade, second only to Japan in the Asian-Pacific region.
  • Growth in the Singaporean pharmaceuticals market has helped the city-state become a regional hub for the manufacturing, research and development for multinational pharmaceutical companies.
SCOPE
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Singapore
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts
REASONS TO BUY
  • What was the size of the Singapore pharmaceuticals market by value in 2016?
  • What will be the size of the Singapore pharmaceuticals market in 2021?
  • What factors are affecting the strength of competition in the Singapore pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in Singapore's pharmaceuticals market?
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Astellas Pharma Inc.
GlaxoSmithKline Plc
Novartis AG
Pfizer Inc.
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: Singapore pharmaceuticals market value: $ billion, 2012–16
Table 2: Singapore pharmaceuticals market geography segmentation: $ billion, 2016
Table 3: Singapore pharmaceuticals market share: % share, by value, 2016
Table 4: Singapore pharmaceuticals market value forecast: $ billion, 2016–21
Table 5: Astellas Pharma Inc.: key facts
Table 6: Astellas Pharma Inc.: key financials ($)
Table 7: Astellas Pharma Inc.: key financials (¥)
Table 8: Astellas Pharma Inc.: key financial ratios
Table 9: GlaxoSmithKline Plc: key facts
Table 10: GlaxoSmithKline Plc: key financials ($)
Table 11: GlaxoSmithKline Plc: key financials (£)
Table 12: GlaxoSmithKline Plc: key financial ratios
Table 13: Novartis AG: key facts
Table 14: Novartis AG: key financials ($)
Table 15: Novartis AG: key financial ratios
Table 16: Pfizer Inc.: key facts
Table 17: Pfizer Inc.: key financials ($)
Table 18: Pfizer Inc.: key financial ratios
Table 19: Singapore size of population (million), 2012–16
Table 20: Singapore gdp (constant 2005 prices, $ billion), 2012–16
Table 21: Singapore gdp (current prices, $ billion), 2012–16
Table 22: Singapore inflation, 2012–16
Table 23: Singapore consumer price index (absolute), 2012–16
Table 24: Singapore exchange rate, 2012–16

LIST OF FIGURES

Figure 1: Singapore pharmaceuticals market value: $ billion, 2012–16
Figure 2: Singapore pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 3: Singapore pharmaceuticals market share: % share, by value, 2016
Figure 4: Singapore pharmaceuticals market value forecast: $ billion, 2016–21
Figure 5: Forces driving competition in the pharmaceuticals market in Singapore, 2016
Figure 6: Drivers of buyer power in the pharmaceuticals market in Singapore, 2016
Figure 7: Drivers of supplier power in the pharmaceuticals market in Singapore, 2016
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2016
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2016
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2016
Figure 11: Astellas Pharma Inc.: revenues & profitability
Figure 12: Astellas Pharma Inc.: assets & liabilities
Figure 13: GlaxoSmithKline Plc: revenues & profitability
Figure 14: GlaxoSmithKline Plc: assets & liabilities
Figure 15: Novartis AG: revenues & profitability
Figure 16: Novartis AG: assets & liabilities
Figure 17: Pfizer Inc.: revenues & profitability
Figure 18: Pfizer Inc.: assets & liabilities

COMPANIES MENTIONED

Astellas Pharma Inc.
GlaxoSmithKline Plc
Novartis AG
Pfizer Inc.
Skip to top


OTC Pharmaceuticals in Singapore US$ 315.00 Sep, 2016 · 40 pages
Pharmaceuticals Global Industry Almanac 2017 US$ 2,545.75 May, 2017 · 505 pages

Ask Your Question

Pharmaceuticals in Singapore
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: